Featured
Green Arms’ Shared Energy at its Fourth Equity Crowdfunding Round
The company Green Arms had already participated in three equity crowdfunding campaigns: the first, in 2019 ended with a collection of $708,000 (€649,000), the second, in 2020, exceeded $1.09 million (€1 million) for a total of 170 investors and the third, in December 2021, closed at $615,470 (€564,185) with 90 investors. Banca Etica has confirmed the ESG label to Green Arms also for this fourth campaign
Green Arms opens a new equity crowdfunding round on the vertical platform Ecomill, the first Italian crowdinvesting platform that aims to facilitate the meeting between supply and demand of capital in the areas of energy transition, and sustainability.
If you want to read more details about Green Arms and its latest equity crowdfunding round, download for free our companion app. The Born2Invest mobile app, available for both Android and iOS devices, keeps its readers up to date with the most important business headlines of the day.
Green Arms buys, builds, and intermediates 100% renewable energy plants
The company had already participated in three equity crowdfunding campaigns: the first, in 2019 ended with a collection of $708,000 (€649,000), the second, in 2020, exceeded $1.09 million (€1 million) for a total of 170 investors and the third, in December 2021, closed at $615,470 (€564,185) with 90 investors.
Green Arms buys, builds, and intermediates 100% renewable energy plants and aims to spread in Italy an innovative model of shared energy, which allows citizens and businesses to invest directly in clean energy production projects. Green Arms expands the sharing model already developed and validated by the proponents with the Positive Energy (2015) and EPco (2019) initiatives. Through these two cooperatives, which now aggregate over 750 entities, citizens and businesses can subscribe to shares of “renewable” plants, directly lowering the cost of their utility bills.
Green Arms, however, takes a further step forward. The goal, in fact, is to offer everyone the opportunity to participate, invest and earn from investments in photovoltaic and hydroelectric plants, even without the correspondence with a bill.
The company has also chosen to remunerate crowd investors with an ethical profit distribution mechanism aimed at protecting smaller investors. Green Arms has in fact demonstrated to those who have already invested in previous campaigns that it can achieve significant annual economic results by allowing them to participate in a business that can generate very attractive expected returns related to investments in clean energy.
The company has also chosen to remunerate crowd investors with an ethical profit distribution mechanism
Green Arms, which will become an innovative SME later this year, plans to pay investors dividends and capital repayments based on cash flow and in a manner that optimizes taxation and returns. The activities and investments of Green Arms in renewable energy plants are long-term and made with the aim of offering a stable and long-lasting income to its shareholders.
Finally, it should be noted that Banca Etica has confirmed the ESG (Environmental, Social and Governance) label to Green Arms also for this fourth campaign, thus certifying the sustainability of the company’s proposal, its policies aimed at environmental protection, work ethics and energy saving.
__
(Featured image by Alexas_Fotos via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Crowdfunding buzz, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Africa2 weeks ago
Souss-Massa Launches ‘Back to Business’: Accelerating Investment with Bold Strategies
-
Biotech5 days ago
Vytrus Biotech Reports Its Best Quarter: Record Revenue and Rising EBITDA
-
Cannabis1 week ago
Ireland: Legislative Committee Calls for Legalization of Cannabis and Decriminalization of Drugs
-
Biotech2 days ago
Dijon Biotech Company Inventiva Raises 348 Million to Complete Its Phase III